Literature DB >> 8977900

Pathogenesis and immunology of Listeria monocytogenes.

W F Schlech1.   

Abstract

Listeriosis is primarily a foodborne disease and the pathogenesis of infection is determined by passage of the organism from the gastrointestinal lumen to the reticuloendothelial cells of the liver and spleen. Subsequent invasive events such as sepsis and meningitis develop. The immune response to Listeria is characterized by early macrophage mediated killing followed by the development of a brisk cell mediated immune response. Humoral immunity appears to play no role in infection in the protected response. Organism specific virulence factors such as hemolysin and actin polymerization factor may play important roles in pathogenesis and also illicit specific immune responses. Immunization against listeriosis has been carried in animals but does not appear feasible for this rare infection in human populations.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8977900

Source DB:  PubMed          Journal:  Pathol Biol (Paris)        ISSN: 0369-8114


  4 in total

1.  Identification of Listeria species by microarray-based assay.

Authors:  Dmitriy Volokhov; Avraham Rasooly; Konstantin Chumakov; Vladimir Chizhikov
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

2.  The role of the pH conditions of growth on the bioadhesion of individual and lawns of pathogenic Listeria monocytogenes cells.

Authors:  Bong-Jae Park; Nehal I Abu-Lail
Journal:  J Colloid Interface Sci       Date:  2011-03-12       Impact factor: 8.128

3.  Use of monoclonal antibodies that recognize p60 for identification of Listeria monocytogenes.

Authors:  Kang-Y Yu; Youngsoon Noh; Minsub Chung; Hong-J Park; Namseok Lee; Moonyeon Youn; Byeong Y Jung; Byung-S Youn
Journal:  Clin Diagn Lab Immunol       Date:  2004-05

4.  Listeria monocytogenes sigmaB modulates PrfA-mediated virulence factor expression.

Authors:  Juliane Ollinger; Barbara Bowen; Martin Wiedmann; Kathryn J Boor; Teresa M Bergholz
Journal:  Infect Immun       Date:  2009-03-02       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.